Kusum drugs used in the treatment of epilepsy are included in the Register of drugs that are subject to reimbursement under the program of state guarantees of medical care. From now on, patients with neurological diseases have even more opportunities to receive high-quality and efficient drugs with the active substances Carbamazepine, Lamotrigine, Valproate sodium and Fluoxetine manufactured by Kusum.
“We are proud that thanks to reimbursement programs, even more patients will receive high-quality, efficient drugs that will help them fight their illnesses. And we, in turn, will do everything in our power to meet the needs of patients. Kusum is always here to help you”, Rajeev Gupta, Managing Director of Kusum Group of Companies, said.